Loading organizations...
Initiate Ventures is a San Francisco-based venture capital firm investing in early-stage startups at the intersection of life sciences, healthcare, and technology, while also incubating new companies in-house through its venture studio. The firm raised a $45 million debut fund in 2024, targeting seed and Series A investments with check sizes from $500,000 to $3 million. Its team's prior experience spans 18 company initiations, 6 IPOs, and 5 M&As, contributing to over $40 billion in market capitalization. By late 2024, Initiate Ventures had incubated five startups, four securing follow-on financing, including portfolio company Persana. Co-founder Jessica Owens previously co-founded GRAIL, acquired by Illumina for $8 billion. Initiate Ventures was founded in 2020 by Jessica Owens and Iana Dimkova.
Initiate Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $6.0M Seed in Macro Trials in June 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2023 | Macro Trials | $6.0M Seed | MBX Capital | Cota Capital, General Catalyst, Pear VC, Plug & Play Ventures, Anne Wojcicki, Jennifer LUM, Healthy Ventures, Inflect Health, Village Global |
| Jul 1, 2022 | Delfi Diagnostics | $230.0M Series B | Justin KAO | Canvas Ventures, DFJ Growth, Jenny Fielding, Scott Hartley, Menlo Ventures, OrbiMed, Westlake Village BioPartners, AV8 Ventures, Brown Advisory, Cowen Healthcare Investments, ELI Lilly And Company, Foresite Capital, Illumina Ventures, Anthology Fund, Northpond Ventures, Open Field Capital, Point72, Point Field Partners, PTX Capital, Rock Springs Capital, Samsara BioCapital, T. Rowe Price Associates, Windham Venture Partners |
